NCT07401160 Umbilical Cord Drainage to Prevent Postpartum Hemorrhage
| NCT ID | NCT07401160 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Nacional Autonoma de Honduras |
| Condition | Postpartum Hemorrhage |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2026-02-15 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2026-02-15 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to analyze whether there is a significant difference in the occurrence of postpartum hemorrhage between women who underwent umbilical cord drainage and those who did not. Variables such as estimated blood loss volume, drop in hemoglobin levels, and the need for additional maneuvers or treatments to control hemorrhage will be examined. The research will be conducted under a parallel-group clinical trial design at the Hospital Escuela Universitario. Post-birth umbilical cord drainage may contribute to a lower frequency of postpartum hemorrhage compared to not performing it.
Eligibility Criteria
Inclusion Criteria: * Pregnant women aged 18-49 years. * Singleton pregnancy. * Gestational age ≥37 weeks. * active labor with cephalic presentation. * Planned for vaginal delivery. * Capable of providing informed consent. Exclusion Criteria: * Planned or emergent cesarean section. * Instrumental delivery (e.g., forceps, vacuum). * Antepartum hemorrhage. * Severe anemia (Hemoglobin \<8 g/dL) or specific hematological disorders (e.g., sickle cell disease, thalassemia, hemophilia, thrombocytopenia \<100,000/µL). * Use of anticoagulant medication. * Non-cephalic fetal presentation (e.g., breech, transverse). * Refusal to participate or inability to provide informed consent.
Frequently Asked Questions
Who can join the NCT07401160 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 49 Years, studying Postpartum Hemorrhage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07401160 currently recruiting?
Yes, NCT07401160 is actively recruiting participants. Visit ClinicalTrials.gov or contact Universidad Nacional Autonoma de Honduras to inquire about joining.
Where is the NCT07401160 trial being conducted?
This trial is being conducted at Tegucigalpa, Honduras, Tegucigalpa, Honduras.
Who is sponsoring the NCT07401160 clinical trial?
NCT07401160 is sponsored by Universidad Nacional Autonoma de Honduras. The trial plans to enroll 400 participants.